Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · University Hospital, Grenoble
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Spondylarthritis, Inflammatory Bowel Diseases and Crohn Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Patient with an inflammatory bowel disease according to gastroenterologist
There are also 5 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 220 participants are expected to take part.
- Start date: 2025-05 (planned).
- Main results expected around 2026-04 (estimate from the record).
- 1 study site listed in France.
Main thing being measured
- translation and cross-cultural adaptation in french of the questionnaires developped by Di Marco et al (2017) and Variola et al (2020) (13 months)
In the researchers’ words
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease. DETAIL (DETection of Arthritis in Inflammatory boweL diseases) and IBIS-Q (Inflammatory Bowel disease Identification of Spondyloarthritis Questionnaire) questionnaires are built to determine which patients might benefit from a rheumatologic…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Spondylarthritis; Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis; Spondylitis, Ankylosing |
| Lead sponsor | University Hospital, Grenoble |
| Collaborators | Clinique des Cèdres, Echirolles |
| Enrollment | 220 (estimated) |
| Start date | 2025-05 |
| Primary completion (est.) | 2026-04 |
| First posted | 2025-05-31 |
| Last updated | 2025-05-31 |
| Official title | Linguistical Validation of a Spondylo-arthritis Screening Tool for Patients Suffering From Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT06998316 |
Interventions
- Screening questionnaire (Other)
Every patient will answer the 2 screening questionnaires given to them, once at baseline and a second time after 1 month.
Full eligibility criteria (from the record)
Inclusion Criteria: * Patient with an inflammatory bowel disease according to gastroenterologist Exclusion Criteria: * No exclusion criteria * Difficulty for understanding or reading french * Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code * Patients with no social security coverage. * Patients refusing to participate voluntarily.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Grenoble | Grenoble | France |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.